Skip to content

Retrospective, multicenter clinical study on high-risk factors and prognosis analysis of geometric features of Stanford type B aortic dissection

Retrospective, multicenter clinical study on high-risk factors and prognosis analysis of geometric features of Stanford type B aortic dissection

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400082765
Enrollment
Unknown
Registered
2024-04-07
Start date
2024-04-11
Completion date
Unknown
Last updated
2024-04-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

aortic dissection

Interventions

strong chirality group:NA
weak chirality group:NA

Sponsors

Zhongshan Hospital Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: ? Age =18 years old, no gender limit; ? Diagnosed with Stanford type B dissection, and repaired with a thoracic aortic stent system, including a simple covered stent system, or a covered stent combined with a bare stent system; ? Have a suitable arterial access and be suitable for aortic endovascular treatment; ? Subjects who can understand the purpose of the trial, voluntarily participate in this study, the subject himself or his legal representative signs the informed consent form, and are willing to complete the follow-up in accordance with the protocol requirements.

Exclusion criteria

Exclusion criteria: ? The patient has participated in other clinical trials of drugs or medical devices related to the treatment of target lesions, or has participated in other clinical trials of drugs or medical devices but failed to reach the primary research endpoint; ? The patient is unable or unwilling to participate in this study; ? The researcher determines that the patient is not suitable to participate in this trial; ? Those who are allergic to iodine contrast media.

Design outcomes

Primary

MeasureTime frame
all-cause mortality;

Secondary

MeasureTime frame
aorta-related death;Major adverse events within 30 days after surgery;Re intervention rate;

Countries

China

Contacts

Public ContactWeiguo Fu

Zhongshan Hospital Fudan University

fu.weiguo@zs-hospital.sh.cn+86 21 6404 1990

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026